Top compounds associated with response to TSPAN11


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.06
mRNA alvocidib CTRPv2 pan-cancer AAC 0.093 0.06
mRNA XMD11-85h GDSC1000 pan-cancer AAC 0.093 0.06
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.06
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.064 0.07
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.18 0.07
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.058 0.07
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.1 0.07
mRNA PF-562271 GDSC1000 pan-cancer AAC -0.064 0.07
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.064 0.07
Download CSV